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Abstract 
Evidence is accumulating that hematological malignancies develop following acquisition of 
multiple genetic changes. Despite providing many insights into the way by which given 
genetic changes contribute to the development of disease, the generation of animal models 
is often laborious. Here we show a simplified method that allows the retroviral transduction 
of genes of interest into mouse B or T cells, thus leading to the rapid generation of models of 
lymphoid neoplasm in mice. Specifically, germinal center B cells induced in vitro from naïve 
mouse B cells and infected with retroviruses for Myc and Bcl2 rapidly developed a neoplasm 
of immunoglobulin-expressing mature B cells in transplanted mice. Likewise, T cells induced 
in vitro from immature hematopoietic cells and infected with retroviruses for Myc, Bcl2 and 
Ccnd1 rapidly developed CD4+CD8- and CD4+CD8+ T cell neoplasm in transplanted mice. 
These findings support the utility of our simplified method as a versatile tool for lymphoma 
research.  
 
Introduction 
Evidence is accumulating to suggest that lymphomas develop as a result of the acquisition 
of multiple genetic changes. Although Myc is a potent oncogene, transgenic expression of 
Myc alone in the lymphoid compartment of hematopoietic cells in mice appears insufficient 
to elicit the development of lymphoma, as myc-expressing pre-B cells expand as a benign 
state in E-Myc transgenic mice [1][2]. Subsequent experiments employing compound mice 
generated by crossing transgenic mice have unequivocally shown that Myc collaborates 
with genes such as Bcl2 [3], Ccnd1 [4] and Bmi1 [5] to induce lymphoma in mice. Although 
these experiments are valuable, the generation and crossing of genetically engineered mice 
to facilitate multiple gene expression is laborious, thus making it difficult to study the roles of 
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combinations of multiple genes in the development of lymphomas. In this respect, use of a 
mouse transplantation model employing retroviral gene transduction into hematopoietic cells 
is feasible in many cases. However, this type of approach has been hampered by a lack of 
established methods that allow efficient gene transduction into normal counterparts of cells 
in which lymphomas originate, such as germinal center B (GCB) cells. In the study 
presented here, we induced GCB cells in vitro, facilitated the expression of multiple genes of 
interest through retroviral transduction, and then transplanted the gene-transduced cells into 
mice. Given that “double-hit” lymphomas involving deregulated expression of Myc and Bcl2 
[6] represent a clinically dismal disease, we chose to model the lymphoma by employing our 
methodology in order to demonstrate the utility of our system for lymphoma research. In a 
similar initiative, we utilized T cells induced from hematopoietic progenitor cells for retroviral 
gene transduction and subsequent generation of mouse models of T cell neoplasms. 
 
Materials and methods 
 
Induction of GCB cells in vitro, retroviral infection, and transplantation 
Induction of GCB cells was performed essentially as described in the literature [7]. Briefly, 
B220+ B cells isolated from the spleens of C57BL/6 mice were co-cultured with 
X-ray(150-Gy)-irradiated NIH3T3 cells engineered to express mouse CD40 ligand and 
mouse Baff (3T3/CD40L/Baff cells), in the presence of mouse IL4 (1 ng/ml; PeproTech) for 4 
days. B cells were subsequently transferred onto a new layer of 3T3/CD40L/Baff cells, and 
cultured in the presence of mouse IL21 (10 ng/ml; PeproTech) for 2 days. 3T3/CD40L/Baff 
cells were generated by infecting NIH3T3 cells with retroviruses for mouse Baff 
(MSCV-mouse Baff/pgk-puro
R
) and mouse CD40L (MSCV-mouse CD40l/pgk-blasticidin
R
), 
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and selected for drug resistance with puromycin and blasticidin (Sigma). cDNA for mouse 
Baff was obtained by the PCR method using cDNA from mouse bone marrow and spleen 
cells, and cDNA for mouse CD40L was generously provided by Dr. T. Tsubata (Tokyo 
Medical and Dental University). Retrovirus was produced as described [8] and infected into 
cells on the 5th and 6th days after initiation of the culture. Cells were subsequently 
harvested by vigorous pipetting, filtered through 42-m and 15-m nylon meshes, and 
transplanted (5-10 10
6
 cells) intraperitoneally into NSG mice 
(NOD.Cg-Prkdc
scid
Il2rg
tm1Wjl
/SzJ: purchased from the Jackson Laboratory), or intravenously 
into sublethally irradiated (5 Gy) syngeneic hosts. 
 
Induction of T cells in vitro, retroviral infection, and transplantation 
Fetal liver cells isolated from 14 d.p.c. Balb/c mice (Charles River) were depleted of 
Ter119-positive cells and co-cultured with an X-ray(15-Gy)-irradiated OP9-Dl1 stromal cell 
(RIKEN BRC) layer in the presence of mouse Flt3 (FMS-like tyrosine kinase 3) ligand (5 
ng/mL; PeproTech) and 0.5–1.0% of culture supernatant of the mouse IL-7-producing cell 
line J558L-IL7 (kindly provided by Dr. A. G. Rolink, University of Basel), as described [9]. 
Cells were harvested and seeded at 5×10
4
 cells/well onto a fresh OP9-Dl1 layer every 7 
days. Cells were infected with retrovirus on day15 after initiation of culture, and transplanted 
(7–10×106) intravenously into lethally irradiated syngeneic hosts together with 1x106 fresh 
bone marrow cells for radioprotection. Cells obtained from spleen were used for secondary 
and tertiary transplantations. Purified CD4+ cells were used in some transplantation 
experiments. All animal experiments were performed according to protocols approved by the 
Institutional Animal Care and Use Committee at the Aichi Cancer Center. 
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Retroviral plasmids 
Retroviral vectors for Myc (MSCV-Myc-ires-GFP), Bcl2 (MSCV-Bcl2-ires-human (h) CD8), 
and Myc plus Bcl2 (MSCV-Bcl2-pgk-Myc-ires-GFP) were constructed as described [8]. 
MSCV-Ccnd1-human (h) CD4 was constructed by inserting cDNA for mouse Ccnd1 into the 
EcoRI restriction site of the MSCV-ires-hCD4 vector (a generous gift by Dr. J.G. Cyster, 
UCSD). CSII-EF1-ires2-Venus lentiviral vector was obtained from RIKEN BRC with the 
permission of Drs. H. Miyoshi and A. Miyawaki (RIKEN), and transfected together with 
pCAG-HIVg/p and pCMV-VSVG/RSV-Rev plasmids (RIKEN BRC) into 293T cells to 
produce virus [10]. 
 
Flow cytometry 
Antibodies for mouse B220(RA3-6B2), IgD(11.26c), IgG1(X-56; MiltenyiBiotec), GL7(GL7), 
Fas(15A7), B7-1/CD80(16-1-A1), CD19(1D3), IgM(ll/41), CD38(90), CD138(281-2), Ter-119 
(Ter-119), CD3 (G4.18), CD90.2 (Thy1.2), CD4 (GK1.5), CD8 (53-6.7), TCR (H57-597) and 
CD25 (PC61.5), and antibody for human CD8 (HIT8a; BD Bioscience), were used. 
Antibodies were purchased from eBioscience unless otherwise specified. Flow cytometry 
was performed using a FACSCalibur instrument (BD Bioscience) and FlowJo software ver. 
7.6.5 (Tree Star Inc.).  
 
Histological analysis 
Formalin-fixed and paraffin-embedded tissues were stained with hematoxylin and eosin. For 
immunostaining, anti-Bcl6 (N-3; Santa Cruz), anti-human CD8 (PAB2495; Abnova) and 
anti-GFP (ab290; Abcam) antibodies were used. Biotinylated peanut agglutinin (PNA; 
Vector Laboratories) was used to detect germinal center B cells. 
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Western blot analysis 
Anti-Myc (#9402; CellSignaling Technology), anti-Bcl2 (3F11;PharMingen), anti-Ccnd1(5D4; 
IBL) and anti-tubulin (DM1A; Sigma) antibodies were used. 
 
Analyses of the clonality of cells and somatic hypermutation. 
For analysis of the clonality of lymphoma and somatic hypermutation of associated 
immunoglobulin genes, genomic DNA isolated from GFP+hCD8+ cells was subjected to 
PCR using primers that detect VDJ regions from immunoglobulin heavy chain genes, as 
described in the literature [11][12]. Combinations of forward (VHA, VHE or VHG) and 
reverse (JH4 intron, JH1D, JH2D, JH3D or JH4D) primers were used. The resulting PCR 
products were gel purified, cloned into pCR4-TOPO vector (Invitrogen) and sequenced. VH 
gene usage and VDJ recombination were analysed using IgBLAST 
(http://www.ncbi.nlm.nih.gov/igblast/) and IMGT/V-QUEST (http://www.imgt.org/ 
IMGT_vquest/share/textes/), respectively. The IgH gene sequence was compared with 
germline DNA sequences to determine the frequencies of somatic hypermutation. For 
analysis of the clonality of T cells, PCR-mediated amplification of the Dβ2-Jβ2 fragment was 
performed, as described in the literature [13]. 
 
Statistical analysis  
Kaplan-Meier analysis and the log-rank test were performed using JMP 10.0.0 software 
(SAS Institute Inc.). 
 
Detection of mutations in the Notch1 gene 
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Mutations in the Notch1 gene were detected as previously described [14]. 
 
Results and discussion 
Generation of B cell neoplasm using in vitro-induced germinal center B cells. 
In an effort to transduce genes into mouse germinal center B cells, we utilized in 
vitro-induced germinal center B cells (iGCB) [7] as a target of retroviral infection. B220+ B 
cells were isolated from mouse spleen, cultured with a stromal cell layer that expressed 
mouse CD40 ligand and mouse Baff for 4 days in the presence of IL4, and subsequently 
cultured for 2 days in the presence of IL21. Prior to the initiation of culture, B220+ B cells 
were positive for CD19 and IgM or IgD, but negative for GL7, Fas and B7-1 (Fig. 1A), and 
were thereby compatible with a naïve B cell phenotype. After 6 days of culture, the cells 
became negative for IgM/IgD, and positive for GL7, Fas and B7-1 (Fig. 1B), which was 
compatible with a germinal center B cell phenotype [7]. 
We therefore made use of this culture system for the retroviral transduction of 
genes. Given that “double hit” B cell lymphomas involving Myc and Bcl2 are associated with 
poor prognosis in humans [6], we chose this combination of genes for the retroviral 
transduction and expected an aggressive lymphoma to develop as proof of the principles 
underlying our gene transduction system for the generation of lymphoma models. 
Retroviruses were infected into cells on the 5th and 6th days after initiation of the co-culture. 
Retroviruses were engineered to co-express GFP or an extracellular domain of human CD8 
(hCD8) as surrogate markers for expression of Myc and Bcl2, respectively, thus facilitating 
identification of cells transduced with the respective gene. GFP-only virus was included as a 
control. Following infection with retroviruses, GFP-only-infected cells were B7-1-positive (+) 
with ~70% of cells being IgG1+, a phenotype comparable to GFP-negative (-) cells in the 
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same culture, although the degree of expression of IgG1 varied from experiment to 
experiment (Supplementary Fig.1). In the case of cells co-infected with retroviruses for Myc 
(GFP) and Bcl2 (hCD8), fractions corresponding to GFP+hCD8+, GFP+hCD8-, GFP-hCD8+ 
and GFP-hCD8- comprised 18–32% (Fig. 1C). The expression of CD19, B7-1, IgG1 and IgM 
was comparable between GFP+ and GFP- fractions, and comparable to that of 
GFP-only-infected cells (Fig. 1C). Furthermore, the expression was also comparable among 
the four fractions defined by GFP and hCD8 in an independent experiment (Supplementary 
Fig. 1). 
We then transplanted the gene-transduced iGCB cells into mice. Our initial 
experiments made use of immune-deficient mice as recipients. To this end, a mixture of the 
four fractions, generated as a result of infection with retroviruses for Myc(GFP) and 
Bcl2(hCD8), was intraperitoneally transplanted into NSG mice. GFP-only-infected control 
cells were similarly transplanted. Although mice did not show apparent signs of disease after 
four weeks, they were sacrificed to examine the transplanted cells. While GFP-only-infected 
cells were virtually undetectable, Myc/Bcl2-infected cells were readily indentified, and 
indeed almost all B220+ cells in mice were doubly positive for GFP and hCD8, and 
indicative of Myc- and Bcl2-co-expressing cells (Fig. 2A). Although the cells largely lost 
expression of GL7 and Fas, B7-1 was retained (Fig. 2A). Cytospin preparations of BM and 
spleen cells revealed the presence of large lymphoid cells harboring atypical nuclei with 
prominent nucleoli (Fig. 2B). In order to determine the tumorigenicity of the Myc/Bcl2 doubly 
transduced cells, we isolated the cells from the spleen of the primary recipient and 
intravenously transplanted these cells into immune-competent syngeneic mice. Secondary 
recipient mice succumbed to lymphoma within 2 weeks following transplantation and 
exhibited enlargement of lymph nodes (LN), spleen and thymus (Fig. 2C). Diffuse infiltration 
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of atypical large lymphoid cells was noted in LN (Fig. 2D) and spleen, and the histological 
findings were compatible with diffuse large lymphoma. The presence of Myc+Bcl2+ cells 
predominated in these organs (data not shown). 
Finally, we employed immune-competent syngeneic hosts as primary recipients in 
order to confirm the observation made using immune-deficient mice. Intravenous 
transplantation of Myc- and Bcl2-infected cells killed 4 of the 5 mice 30–44 days following 
transplantation (Fig. 3A). The remaining mouse was scarified 39 days following 
transplantation and exhibited enlarged LN, spleen and thymus (Fig. 3B), with the presence 
of atypical large lymphoid cells predominating in various organs including LN, liver and lung. 
Histological findings were compatible with diffuse large lymphoma (Figs 3C and 3D). Flow 
cytometric analysis of spleen cells revealed the predominance of GFP(Myc) and hCD8(Bcl2) 
doubly expressing cells, with GFP+hCD8- being present as a minor population and 
GFP-hCD8+ being virtually undetectable (Fig. 3E). Analyses of cells in LN and thymus 
yielded a similar result to that obtained from spleen cells. Thus, although transplanted cells 
comprised a mixture of cells transduced with Myc and/or Bcl2, Myc- and Bcl2- doubly 
transduced cells acquired a growth advantage over singly-infected cells. Taken together, 
these findings reflect the synergy of the two genes in the development of lymphoma. The 
predominant cells were B220+CD19+ B cells of an IgG1-type (Fig. 3E).  
In an independent experiment, detailed analysis of lymphoma cells in spleen and 
the use of immunostaining (Supplementary Fig. 2) revealed that (1) secondary follicles were 
enlarged, (2) lymphocytes residing in the enlarged follicles were morphologically compatible 
with centrocytes and centroblasts, and (3) GFP+hCD8+ lymphoma cells in the follicles were 
positive for Bcl6 and PNA staining, and therefore compatible with germinal center B cells. 
However, most GFP+hCD8+ lymphoma cells morphologically indistinguishable from those 
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residing in follicles were seen in the red pulp, and this finding is compatible with a diagnosis 
of DLBCL with follicular colonization. Despite bearing a resemblance to lymphoma cells in 
follicles, lymphoma cells in the red pulp were negative for Bcl6 and PNA staining, suggestive 
of non-GCB cells. The fact that there were two different components in the developed 
lymphoma was additionally confirmed by flow-cytometric analysis, which showed that only 
small numbers of GFP+hCD8+ cells were positive for the GCB markers GL7 and Fas 
(Supplementary Fig. 3). Coupled with negativity for plasma cell markers CD138/CD38 
(Supplementary Fig. 3), these findings suggest that the lymphoma cells in the red pulp are 
post-germinal center B cells, which are considered counterparts of many types of 
lymphomas developing in humans [15].  
Analysis of the clonality of evolved lymphoma through PCR-mediated amplification 
of the VDJ region of IgH and sequencing revealed the presence of a single major clone that 
was not accompanied by somatic hypermutation (SHM) (Supplementary Fig. 4). Reasons 
for the absence of SHM in our modeled neoplasm, despite representing post-germinal 
center B cells, are not clear from the present study, but likely reflect very low activity of AID 
in the in vitro-induced GCB cells [7] and the absence of antigenic stimulation in our mice, 
both of which otherwise normally induce SHM in B cells. Importantly, however, in 
vitro-induced GCB cells are known to differentiate into memory B and plasma cells following 
transplantation in vivo, the capacity of which is the hallmark of normal GCB cells [7]. SHM is 
generally thought to be one of the critical components that cause deregulated expression of 
genes such as PIM1[16] and Bcl6 [17], which substantially contribute to lymphomagenesis 
[18][19]. Although our analysis of clonality and SHM was conducted in a single diseased 
mouse, the lack of SHM in our modeled lymphoma suggests the lack of involvement of 
SHM-mediated gene deregulation in the development of lymphoma. The monoclonal nature 
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of the evolved lymphoma (Supplementary Fig. 4) nevertheless suggests the requirement of 
additional genetic or epigenetic abnormality, in addition to overexpression of Myc and Bcl2, 
for lymphoma development. Elucidation of such additional abnormality awaits further 
investigation. 
 
Generation of T cell neoplasm using in vitro-induced T cells 
In a similar initiative, we sought to establish an in vitro culture system that allows 
transduction of genes into T cells. To this end, we used T cells induced from immature 
hematopoietic cells that were cultured with an OP9-Dl1 stromal layer in the presence of 
Flt3-ligand and IL-7 [9]. The fraction of cells (%) that express CD4 and/or CD8 was 
maximized around 21 days after initiation of the culture (Fig. 4A), and the highest efficiency 
of gene transduction was achieved when cells were infected with retrovirus on day 15 after 
initiation of the culture (Supplementary Fig. 5). Cells infected with GFP-only control virus 
were able to differentiate into CD4 and/or CD8 cells with an efficiency comparable to that of 
GFP-uninfected cells (Fig. 4B), although the possibility that retroviral infection affects 
differentiation cannot be entirely excluded. Lentivirus was inefficient in transducing genes 
into T cells in our culture system (Supplementary Fig. 6). 
Given the synergism of Myc and Bcl2 for the development of B cell lymphoma (Figs. 
2 and 3), and our previous observation that Ccnd1 significantly increases the incidence of B 
cell neoplasm [8], we tested whether combinations of Myc, Bcl2 and Ccnd1 could induce T 
cell neoplasm utilizing the T cells induced in vitro as described above as a target of gene 
expression. Our investigation of gene expression data (GSE19069) made available by 
Iqubal et al. [20] additionally shows the presence of peripheral T cell lymphoma cases 
associated with concomitant over-representation of MYC, BCL2 and CCND1 (and/or 
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CCND3) (Supplementary Fig. 7). Thus, cells were infected with retrovirus that co-expresses 
Myc and Bcl2 (MSCV-Bcl2-pgk-Myc-ires-GFP: Supplementary Fig. 8) alone or in 
combination with retrovirus for Ccnd1 (MSCV-Ccnd1-ires-human CD4) on day 15 after 
initiation of the co-culture, and intravenously transplanted (0.7–1.0 x 107 cells) into lethally 
irradiated syngeneic hosts, along with radioprotective bone marrow cells. All 6 mice 
transplanted with Bcl2/Myc/Ccnd1-transduced T cells became moribund or died within 48 
days after the transplantation. In contrast, only 3 of the 6 mice transplanted with 
Bcl2/Myc-transduced T cells became moribund or died, and the latency was significantly 
delayed compared with that of mice transplanted with Bcl2/Myc/Ccnd1-transduced cells (Fig. 
5A). One of the two mice transplanted with GFP only-transduced cells was electively 
sacrificed 28 days after the transplantation and was without detectable GFP-positive cells 
(data not shown), suggesting that GFP-only transduced cells do not grow efficiently in vivo. 
The other mouse transplanted with GFP-only-transduced cells and 3 mice transplanted with 
hCD4 only-transduced cells (all considered controls) showed no sign of disease at least until 
120 days after the transplantation (Fig. 5A). 
Diseased mice that received a transplant with Bcl2/Myc/Ccnd1-transduced T cells 
exhibited enlarged thymus, spleen and lymph nodes (n=2) (Fig. 5B), which were 
accompanied by diffuse infiltration of atypical large lymphoid cells, and the histological 
findings were compatible with diffuse large lymphoma (Fig. 5B). The remaining 4 mice that 
died also exhibited enlarged spleen upon autopsy. Flow-cytometric analysis of cells in bone 
marrow, thymus, spleen and lymph nodes in the diseased mice revealed that at least 70% of 
cells were positive for both GFP and hCD4, indicating the predominance of 
Myc/Bcl2/Ccnd1-cotransduced cells (Fig. 5C). The predominant cells were CD4 
single-positive or CD4/CD8 double-positive T cells. The presence of two populations 
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regarding hCD4 expression in some organs likely reflect polyclonal nature of the neoplasm 
(description follows). Upon secondary transplantation of spleen cells, all 6 mice (two 
experiments employing 3 mice each) succumbed to the CD4+ T cell malignancy 18–48 days 
after the transplantation. Given the predominance of CD4 single-positive T cells in bone 
marrow, spleen and lymph nodes of the secondary recipient mice albeit CD4+CD8+ T cells 
contributing to neoplasm in thymus (Fig. 5D), we sought to determine whether the 
CD4+cells are able to propagate tumor in mice. Accordingly, column-purified CD4+ cells 
from the spleen of a primary recipient mouse were transplanted into secondary mice. 
Results showed that the secondary mice succumbed to CD4 single-positive T cell 
malignancy (Fig. 5E) 33–35 days following transplantation (n=3). Similarly, CD4+ cells 
purified from the secondary mice also propagated tumor in tertiary recipient mice (data not 
shown). Although the incidence of tumor was lower and latency was prolonged compared 
with that of Myc/Bcl2/Ccnd1-cotransduced cells (Fig. 5A), Myc/Bcl2-cotransduced cells also 
elicited CD4+ tumors following transplantation into mice, which were accompanied by 
enlargement of thymus, spleen and lymph nodes, and the histological findings were 
compatible with diffuse large lymphoma (Supplementary Fig. 9) . Upon secondary 
transplantation, these cells elicited tumor death 40–41 days after the transplantation (n=3). 
Although exons 26, 27 and 34 of the mouse Notch-1 gene are often mutated in T cell 
malignancy in mice [21][22][10], we did not detect such mutations following sequencing of 
cDNA obtained from aroused tumors. The polyclonal nature of the evolved tumors, as 
evidenced by PCR analysis of D2-J2 rearrangements (Supplementary Fig. 10), the 
maintenance of expression of Myc, Bcl2 and Ccnd1 (Supplementary Fig. 11), as well as the 
lack of Notch1 mutation and a short latency, suggest that a combination of Myc, Bcl2 and 
Ccnd1 is sufficient for the development of T cell neoplasm generated by the use of our 
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culture system. The presence of dominant clones in some mice may reflect a growth 
advantage of the selected clones, but the underlying mechanisms are not clear from the 
present study (Supplementary Fig. 10). 
 
Overall, our study presented here demonstrates the utility of our gene transduction 
system that allows rapid analysis of the role of gene combinations in the development of B 
or T cell neoplasm in vivo. Although production of mouse models of lymphoid malignancy 
using retrovirus transduction is not unprecedented, methods hitherto reported are for the 
production of neoplasm of plasma cells and precursor B cells. Largaespada et al. [23] 
injected retrovirus for ABL-MYC into mice to obtain neoplasm of terminally differentiated 
plasma cells. They then generated plasma cell neoplasm models by retroviral transduction 
of activated B cells with ABL-MYC in a short-term in vitro culture [24], while Nakagawa et al. 
[8] generated precursor B cell neoplasm by the in vitro retroviral transduction of fetal 
liver-derived precursor B cells. In contrast, we induced germinal center B cells ex vivo, and 
used the cells as a target of retroviral gene transduction. Importantly, the neoplasm thus 
obtained is that of matured B cells and not of plasma cells or precursor B cells, and 
corresponds to germinal center and post-germinal center B cells. The phenotype of 
neoplasms thus obtained is therefore distinct from those reported by Largaespada and 
Nakagawa. Although E-Myc transgenic mice are widely used for lymphoma research, the 
lymphomas largely comprise precursor B cells (pre-B cells in ~50% and a mixture of pre-B 
and B cells in ~30% of cases) [2], which are usually not seen in humans [15]. In contrast, our 
model represents lymphoma of matured B cells. Additionally, we established a method for 
the generation of T cell neoplasm. Our method therefore could complement studies using 
time-consuming and costly investigations such as those employing transgenic and knock-in 
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technologies, and would facilitate progress in the area of lymphoma research. 
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Figure legends 
 
Figure 1. Induction of germinal center B cells in vitro and retroviral gene-transduction. 
(A) Flow cytometric analysis of spleen B cells prior to induction. (B) Flow cytometric analysis 
of iGCB cells. Note that IgM and IgD were down-regulated and germinal center-associated 
molecules (GL7, Fas and B7-1) were up-regulated. (C) Retroviral gene transduction into 
cells. Upper panels: retrovirus for GFP-only control was infected into cells during the 
induction period of GCB cells. Lower panels: retroviruses for Myc and Bcl2 that respectively 
co-express GFP and hCD8, as surrogate markers, were similarly infected into cells. Infected 
cells were analyzed for expression of the indicated molecules. No appreciable difference 
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was noted with respect to expression of differentiation-associated molecules regardless of 
gene-transduction.  
 
Figure 2. Development of lymphoma in immune-deficient mice. (A) iGCB cells infected 
with retroviruses for Myc and Bcl2, as shown in Fig. 1C, were transplanted into an NSG 
mouse, and B220+ B cells in bone marrow (BM), spleen and liver were analyzed for the 
expression of GFP (representing Myc expression) and hCD8 (representing Bcl2), along with 
various germinal center-associated molecules. (B) May-Grunwald-Giemsa staining of cells 
in BM and spleen (x100 objective). (C) Gross anatomy of a C57BL/6 mouse secondarily 
transplanted with spleen cells shown in (A). Note enlarged lymph nodes (LN), spleen and 
thymus. (D) Hematoxylin and eosin staining of a lymph node (upper panels: x4 objective, 
lower panels: x40 objective).  
 
Figure 3. Development of lymphoma in immune-competent mice. (A) A Kaplan-Meier 
curve for the probability of disease-free survival following transplantation of Myc- and 
Bcl2-co-transduced iGCB cells. Death or moribundity was considered an event. (B) Gross 
anatomy of a diseased mouse, which shows enlarged lymph nodes (LN), spleen and thymus. 
(C) May-Grunwald-Giemsa staining of cells in spleen and LN (x100 objective). (D) 
Hematoxylin and eosin staining of tissues (upper panels: x4 objective, lower panels: x40 
objective). (E) Flow cytometric analysis of spleen cells for expression of GFP(Myc) and 
hCD8(Bcl2)(left), and the indicated B cell-associated molecules on GFP+ cells (right). 
 
Figure 4. Establishment of an in vitro culture system that allows retroviral transduction of 
genes into T cells. (A) Differentiation of T cells from mouse fetal liver cells. Ter119-depleted 
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mouse fetal liver cells were cultured with an OP9/Dl1 stromal cell layer in the presence of 
Flt3-ligand and IL7. Expression of T cell-affiliated markers was analyzed by flow cytometry 
on the indicated days after initiation of the culture. Numbers shown represent percentages 
of respective fractions. (B) Differentiation of GFP-transduced cells. Cells infected with 
GFP-only retrovirus on the 15
th
 day after initiation of the culture were monitored for 
differentiation 6 days later. Differentiation potential of GFP-transduced cells appears 
comparable with that of GFP-negative untransduced cells.  
 
Figure 5. Tumorigenicity of gene-transduced T cells in vivo. (A) A Kaplan-Meier curve 
representing disease-free survival, in which death and moribundity were considered events. 
Cells transduced with the indicated genes were intravenously transplanted (0.7–1.0☓107 
cells) into syngeneic hosts. Mice transplanted with cells infected with viruses for GFP-only 
(n=2) and hCD4-only (n=3) were combined and considered a control group (n=5). The 
difference in probability of disease-free survival was statistically significant as estimated by 
the log-rank test. (B) Gross anatomy of a diseased mouse that received a transplant with 
Bcl2/Myc/Ccnd1-transduced cells. Note that the thymus (open triangles), spleen (filled 
triangles) and lymph nodes (circle) were enlarged. Histology (spleen and lymph nodes) is 
also presented (upper panels: x4 objective, lower panels: x40 objective). (C) 
Flow-cytometric analysis of a diseased mouse. Expression of GFP (representing expression 
of Bcl2/Myc) and human CD4 (representing expression of Ccnd1) in cells of various organs 
are presented, along with expression of T cell-affiliated markers on GFP+ cells. Note that 
GFP+hCD4+ cells predominated in all organs analyzed. (D) Flow-cytometric analysis of a 
diseased mouse that received a transplant with spleen cells of a primary recipient mouse. 
(E) Flow-cytometric analysis of a diseased mouse that received a transplant with CD4+ cells 
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purified from spleen cells of a primary recipient mouse. Note that CD4+CD8- cells 
predominated in the organs of the secondary recipient mouse.  
 
 
 
 





Supplementary Figure Legends 
 
Supplementary Fig. 1. 
Flow cytometric analysis of Bcl2/Myc co-transduced iGCB cells before transplantation. Cells 
in the four fractions determined by positivity of GFP (representing Myc expression) and/or 
hCD8 (representing Bcl2 expression) were analyzed for expression of CD19, B7.1, IgM and 
IgG1. 
 
Supplementary Fig. 2. 
Histological analyses of spleens of mice. (A) Hematoxylin and eosin staining of spleens of 
normal (left) and diseased (right) mice with the indicated original magnification. (B) Staining 
of spleens of normal (left) and diseased (right) mice with anti-Bcl6, PNA, anti-GFP and 
anti-human CD8. Original magnifications are also presented. 
 
Supplementary Fig. 3. 
Flow cytometric analysis of the expression of Fas and GL7. (A) Spleen cells of a normal 
C57BL/6 mouse (left) and those of a mouse immunized thrice with sheep red blood cells 
(right). (B) iGCB cells in culture. (C) Spleen cells of a C57BL/6 mouse transplanted with 
Bcl2/Myc-co-transduced iGCB cells. Note that GL7+Fas+ cells that are considered germinal 
center B cells are evident in spleen of an immunized mouse (A; right) and iGCB cells in 
culture (B), but not in spleen cells of a normal mouse (A; left) and GFP+ lymphoma cells in 
spleen of a mouse transplanted with Myc- and Bcl2-co-transduced iGCB cells (C). Plasma 
cells defined by CD138+CD38+ were barely detected in the GFP+ fraction (C). 
 
Supplementary Fig. 4. 
Analysis of the clonality and somatic hypermutation of immunoglobulin genes of 
GFP+hCD8+ tumor cells purified from spleen of an affected mouse. (A) Electrophoresis of 
PCR products using VHA and JH4 intron primers showing a single band. : non-specific 
band. (B) VH gene usage determined by the IgBLAST program. No somatic hypermutation 
was observed. (C) IgH VDJ rearrangement determined by the IMGT/V-QUEST program. 
Productive in-frame rearrangement carrying no somatic hypermutation was observed. 
 
Supplementary Fig. 5. 
Efficiency of retroviral transduction of a gene into T cells. Cells were infected with retrovirus 
for GFP on days 3, 9, 15, 21 and 27 after the initiation of culture, and monitored for 
expression of GFP every 3 days after the infection until the 30th day after the initiation of 
culture. Note that the highest efficiency of gene transduction was achieved when cells were 
infected on day 15 after initiation of culture. 
 
Supplementary Fig. 6. 
Comparison of infection into T cells between retrovirus and lentivirus. Cells were infected on 
the indicated days after the initiation of culture, and the % of transduced cells (represented 
by %GFP) was monitored 3-6 days later. The efficiency of lentiviral infection into K562 cells 
is also presented to show that the absence of lentiviral infection into T cells is not due to 
inefficient production of virus. 
 
Supplementary Fig. 7. 
Expressions of MYC, BCL2 and CCND1-3 in cases with peripheral T cell lymphoma. Gene 
expression data (GSE19069) were used for clustering with Cluster 3.0 software 
(http://bonsai.hgc.jp/~mdehoon/software/cluster/). Arrows indicate cases with concomitant 
over-representation of MYC, BCL2 and CCND1/2/3. 
 
Supplementary Fig. 8. 
Schematic drawings of retroviral plasmids (not to scale). Positions of primers used in 
Supplementary Fig. 11C are shown by arrows. 
 
Supplementary Fig. 9. 
Flow-cytometric analysis and histology of the organs of a mouse transplanted with T cells 
transduced with Myc and Bcl2. 
 
Supplementary Fig. 10. 
PCR analysis of the clonality of T cell neoplasms. The presence of more than one band for 
amplified Dβ2-Jβ2 fragments suggests oligo-clonality of evolved neoplasms. Note that the 
tail DNA exhibits only a single germ line band (indicated by an arrow head). 1st: primary 
recipient, 2nd: secondary recipient, 3rd: tertiary recipient, CD4+: a recipient of purified CD4+ 
cells. 1-2nd represents a mouse that received a graft from the 1-1st mouse. 2-2nd 
represents a mouse that received a graft from the 2-1st mouse. 2-3rd represents a mouse 
that received a graft from the 2-2nd mouse. 
 
Supplementary Fig. 11. 
Expression of Bcl2, Myc and Ccnd1 in neoplasm. (A) Tumor cells were analysed for the 
expression of various proteins. Analysis of tubulin expression was included to allow 
comparison of loaded protein amounts. Normal thymus served as a control. (B) Relative 
amount of protein expressed, with that of a 1-1st mouse being set as 1.0. (C) RT-PCR 
analysis of the expression of retrovirally transduced Myc. The primer set 
5’-GAAAAGGCCCCCAAGGTAGT-3’ and 5’-TATGGTGGAAAATAACATATAGAC-3’ 
(positions are shown in Supplementary Fig. 8) was used. Note that although Myc protein 
expression in some tumors is not dissimilar to that of normal thymus, RT-PCR analysis 
confirms the expression of transduced Myc. RT-: without reverse transcription, RT+: with 
reverse transcription. See the legend to Supplementary Fig. 10 for descriptions of 1-1st, 
1-2nd, 2-1st, 2-2nd, 2-3rd and CD4+. 
 
 








